News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Andrea Necchi: Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI
Dec 25, 2024, 14:47

Andrea Necchi: Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI

Andrea Necchi, Associate Editor of the Journal of Clinical Oncology, shared a recent article on X:

“Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Muscle-invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI in Radiology.”

Title: Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Muscle-invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI

Authors: Giorgio Brembilla , Giuseppe Basile, Michele Cosenza, Francesco Giganti, Andrea Del Prete, Tommaso Russo, Renato Pennella, Salvatore Lavalle, Daniele Raggi, Chiara Mercinelli, Valentina Tateo, Antonio Cigliola, Damiano Patanè, Emanuele Crupi, Patrizia Giannatempo, Antonella Messina, Giuseppina Calareso, Alberto Martini, Marco Bandini, Marco Moschini, Gianpiero Cardone, Alberto Briganti, Francesco Montorsi, Andrea Necchi and Francesco De Cobelli

Andrea Necchi

“Are you searching for the largest study on VIRADS?

Here is the Christmas gift from Giorgio Brembilla.”

More posts featuring Andrea Necchi.

Andrea Del Prete Andrea Necchi bladder cancer cancer chemotherapy Francesco De Cobelli Francesco Giganti Giorgio Brembilla Giuseppe Basile immunotherapy Michele Cosenza MRI OncoDaily Oncology Radiology
Special Coverage
Science
Mar 3, 2025, 15:58
Esranur Aydın: Metastatic IDH2-mutant cholangiocarcinoma treated with venetoclax and decitabine
Science
Mar 3, 2025, 15:56
Selpercatinib in RET Fusion-Positive NSCLC by Oliver Gautschi et al.
Blog
Mar 3, 2025, 15:54
Jihan Azar: Childhood Cancer Inequalities in the WHO Eastern Mediterranean Region
Insight
Mar 3, 2025, 15:53
Arthur Sun Myint: Beacon of hope for patients with rectal cancer wishing to avoid major surgery and a stoma
Blog
Mar 3, 2025, 15:53
Toufic Kachaamy: Aasma Shaukat on how AI might accelerate precision medicine initiatives for CRC prevention
Blog
Mar 3, 2025, 15:52
Magdalena Skipper: An assault of science and scientists anywhere is an assault on science and scientists everywhere
Science
Mar 3, 2025, 15:51
Patrick Hwu: Are B cells important to eliminate cancers?
Blog
Mar 3, 2025, 15:50
Wafaa Rashed: Honored to feature Dr. Mary Relling in PAPERI Bright Minds Series episode
Blog
Mar 3, 2025, 15:49
Wafik El-Deiry: Discussing Legorreta Cancer Center's programmatic leadership
Blog
Mar 3, 2025, 15:48
Registration is open for the ASCO-Endorsed CPOEM Foundation Webinar
Insight
Mar 3, 2025, 15:47
Jill Feldman: ASCO's updated living guidelines for treating stage IV NSCLC
Blog
Mar 3, 2025, 15:47
Uta Dirksen: We have officially opened the first pediatric oncology ward in Eritrea